SMi Reports: In the run up to Immuno-Oncology 2018, SMi announces the conference’s newest session led by ImmuneBiotech AB, as well as an exclusive speaker interview with the MHRA.
SMi Reports: Industry leaders MHRA, Pfizer, Autolus, Tusk Therapeutics, KCL, Boehringer Ingelheim and more are amongst the latest organisations to register for Immuno-Oncology 2018.
SMi Reports: SMi’s Immuno-Oncology Conference is taking place in just under 4 weeks in London, where industry-leading experts will gather to discuss the potential of Immuno-Therapy as an effective cancer therapy.
Today, the Australasian Leukaemia and Lymphoma Group (ALLG) is excited to announce the launch of a new clinical trial that aims to improve the treatment of Australian adolescents and young adults with Acute Lymphoblastic Leukaemia (ALL).
Meetings international announces with extreme cheerfulness about the Global experts meet on International Conference on Oncology and Radiology programmed on December 03-04, 2018 in Sydney, Australia with a theme of “Advancements in Oncology and Radiology, different perspectives to cure cancer.”
Chicago based startup Because Love releases two giftable and customizable products to support those going through cancer treatment. The LOVE HEALS Journal and BIG HUG Lap Blanket are both now available for purchase online.
The 2nd International Conference on Cancer Genetics & Epigenetics will be held during November 12th-13th, 2018 at Tokyo, Japan. Theme: “The Milestones of Scientific Contribution Against Cancer Evolution: Research, Trials, Patient Advocacy & Nursing”.
On behalf of Experts Meet on Cancer Therapy, we are pleased to invite you to participate in a two-day conference during November 14-15, 2018 at Melbourne, Australia.
The realization of cancer therapeutics with less of an effect on normal tissues and life of cancer patients is our goal. This goal is still far from being realized, and novel approaches are progressing
Conference Series llc LTD Group welcomes you to attend the “International conference on Cancer Science & Robotics” which is going to be held during November 14-15, 2018 at Melbourne, Australia. The Cancer Science and Robotics 2018 will be a 2 days Event which will includes Keynote Speeches, Academic Session Speakers, Poster Presentation, Workshop, Young Research forum, Exhibition etc.
Company “Russian Pharmaceutical Technologies” (Ruspharmtech) has increased the commercial value of its patent profile by receiving an American patent. The document contains information about originality and innovativeness of company’s development - the drug alofanib, which is the first of class allosteric inhibitor of fibroblast growth factor receptor type 2 (FGFR2) intended for cancer treatment.
Epigenetics and Cancer 2018 conference is mainly focused on the progress of the scientific community against the cancer evolution, may it be research, clinical trials and nursing. Hence, it showcases the new scientific and technical advances in comparison to the ancient theories with a vision of advanced innovation.
Aimed at an audience of senior scientists and oncology specialists involved in targeted vaccines and drug research, Cancer Vaccines 2017 will provide a perfect platform to discuss pioneering clinical developments and the next generation of cancer immunotherapy. The 6th annual show will capture expert insight by honing in on new pathways with novel vaccines, immunotherapies and drug formulations.
This press release is related to the American Brain Tumor Association. This nonprofit organization in the United States dedicated solely to brain tumors support services and programs.
Sequence Health kicked off Breast Cancer Awareness month early this year by supporting our own Kris Altiere and TeamEdith in the September 25th IRONMAN Chattanooga triathlon as she raised money for the Edith Sanford Breast Foundation.
Sequence Health is proud to announce participation in the 2016 Bariatric Coordinator Conference held September 29 - 30 in St. Petersburg Beach, Florida. The event takes place on the beach and will emphasize the value of relationships within the bariatric industry, giving insights into the tools and tactics necessary to develop best medical practice marketing for individual bariatric programs.
Diana Colleluori at Bluebird Bio will discuss, "Quality Control Considerations for Commercialization of Autologous Cell Products" at 3rd Cell & Gene Therapy conference.
Mark Trusheim, MIT to present, "Implementing Precision Medicine, Determining Economic Value under Adaptive Biomedical Innovation Pathways" at the Inaugural Precision Medicine Conference.
Paraskevi Giannakakou, Professor of Pharmacology in Medicine & Principal Investigator at Weill-Cornell Medical College, will give a presentation on, "Drug-Target Engagement in CTCs: From Mechanism to Clinical Application in Prostate Cancer" at GTCbio's 2nd Cancer Markers & Liquid Biopsies Conference to be held on July 6-7, 2016 in Boston, MA.
Robert Weinberg, MIT, will give a presentation, on "Mechanisms of Malignant Progression of Carcinomas" at 2nd Cancer Markers & Liquid Biopsies Conference.
The American brain tumor association, founded in 1973, was the first and is now the only organization in the United States which is committed to providing funds, support services and programs to the brain tumor patients and their families.
Satisfied Users & 
Approved Press Releases
